EX-99.1 2 a05-7265_1ex99d1.htm EX-99.1 SERIES A PREFERRED STOCK REDEMPTION AGREEMENTSeries a Preferred Stock Redemption Agreement • May 5th, 2020 • Texas
THIS SERIES A PREFERRED STOCK REDEMPTION AGREEMENT (the “Agreement”) is made as of the day of April, 2005 (the “Closing Date”), by and among AMERICAN REALTY INVESTORS, INC., a Nevada corporation (“ARI”), TRANSCONTINENTAL REALTY INVESTORS, INC., a Nevada corporation (“TCI”), INCOME OPPORTUNITY REALTY INVESTORS, INC., a Nevada corporation (“IORI” and together with TCI and ARI, the “Series A Stockholders”), INNOVO GROUP, INC., a Delaware corporation (“Innovo”), and Denton R.N. Enterprise, Inc., a Texas corporation (“Denton”). Denton is a party hereto solely for purposes of Sections 4, 7, 9 and 10.
Series A Preferred Stock Redemption AgreementSeries a Preferred Stock Redemption Agreement • July 12th, 2022 • Mosaic ImmunoEngineering Inc. • Biological products, (no disgnostic substances) • California
THIS SERIES A PREFERRED STOCK REDEMPTION AGREEMENT (the "Redemption Agreement") is made this 6th day of July, 2022 (“Effective Date”)by and among (i) Mosaic ImmunoEngineering, Inc., a Delaware corporation ("Mosaic"), f/k/a Patriot Scientific Corporation and (ii) Holocom, Inc., a California corporation (“Holocom”) (collectively referred to as the “Parties”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Restated Articles of Incorporation of Holocom filed February 15, 2007 with the Secretary of State of the State of California, as amended to date (the "Articles of Incorporation").
BladeLogic, Inc. Series A Preferred Stock Redemption AgreementSeries a Preferred Stock Redemption Agreement • June 19th, 2007 • BladeLogic, Inc. • Services-prepackaged software • Delaware
THIS SERIES A PREFERRED STOCK REDEMPTION AGREEMENT (the "Redemption Agreement") is made this 12th day of June, 2007 by and among (i) BladeLogic, Inc., a Delaware corporation (the "Company") and (ii) the parties named as Investors in that certain Common Stock and Series A Preferred Stock Purchase Agreement dated as of September 6, 2001 (collectively, the "Investors"). Capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Seventh Amended and Restated Certificate of Incorporation of the Company filed December 4, 2006 with the Secretary of State of the State of Delaware, as amended to date (the "Certificate of Incorporation").
Amendment No. 1 to Series A Preferred Stock Redemption AgreementSeries a Preferred Stock Redemption Agreement • June 26th, 2023 • Mosaic ImmunoEngineering Inc. • Biological products, (no disgnostic substances)
THIS Amendment No. 1 to the Series A Preferred Stock Redemption Agreement (the “Amendment No. 1”) is made this 21st day of June, 2023 (“Effective Date”) by and among (i) Mosaic ImmunoEngineering, Inc., a Delaware corporation ("Mosaic"), f/k/a Patriot Scientific Corporation and (ii) Holocom, Inc., a California corporation (“Holocom”) (collectively referred to as the “Parties”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Redemption Agreement dated July 6, 2022 or Restated Articles of Incorporation of Holocom filed February 15, 2007 with the Secretary of State of the State of California, as amended to date (the "Articles of Incorporation").
